A-5.01, r. 1 - Regulation respecting clinical activities related to assisted procreation

Full text
20. Prior to any consent required for an assisted procreation activity, a person must be informed by a physician or a health professional of
(1)  the adverse effects of the clinical intervention and the related risks, in particular risks of multiple pregnancy and the person’s own morbidity risks;
(2)  the procedures and their rates of success;
(3)  the possibility that the number of eggs and embryos exceeds the person’s and any spouse’s needs and of the necessity to plan what will become of them;
(4)  the possibility, for the person and any spouse, of withdrawing their consent and of the situations in which it will no longer be possible;
(5)  the necessity to obtain the spouse’s consent before disposing of an embryo, in particular for a parental project or for research purposes;
(6)  the fact that gamete donation may involve a use for clinical or research purposes;
(7)  the necessity for the person and any spouse to express their intents should death, the dissolution of the union or disagreement occurs;
(8)  the fact that the centre will dispose of unused biological material should the person and any spouse fail to establish contact, after the time period provided for in section 24;
(9)  the fact that the biological material will always be used according to the intents expressed, provided that the person and any spouse remain in contact with the centre and pay the conservation fees, where applicable;
(10)  the physician’s obligation to declare information on the treatment in order to provide surveillance of the health of persons who resorted to assisted procreation activities and of the children born of such activities;
(11)  the possibility of long-term follow-up of in vitro fertilization activities, which involves that the person could be contacted again from time to time after the end of activities; and
(12)  the availability of psychological support at the centre.
O.C. 644-2010, s. 20.